- Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species. Gavin, P.J., Suseno, M.T., Thomson, R.B., Gaydos, J.M., Pierson, C.L., Halstead, D.C., Aslanzadeh, J., Brecher, S., Rotstein, C., Brossette, S.E., Peterson, L.R. Antimicrob. Agents Chemother. (2006)